COc1ccc2c(c1)CCc1c(C(=O)Nc3c(C)nn(Cc4ccc(C)cc4)c3C)noc1-2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?